Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | ECE1 | P42892 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | MME | P08473 | 2/20 | 0.35 |
| ▸ | ACE | P12821 | 2/20 | 0.35 |
| ▸ | CPA1 | P15085 | 2/20 | 0.35 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CTH | P32929 | 1/20 | 0.34 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.33 |
| ▸ | LTA4H | P09960 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14056387 | 1.00 | ALDH1A1 (0.41) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL2805307 | 0.97 | ALDH1A1 (0.43) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL2132525 | 0.97 | ALDH1A1 (0.43) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL1700840 | 0.97 | ALDH1A1 (0.43) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| Hydrochloric Acid SCHEMBL10578120 | 0.95 | ALDH1A1 (0.41) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| Boric Acid SCHEMBL31168108 | 0.91 | ALDH1A1 (0.39) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| Alanine SCHEMBL27729429 | 0.89 | ALDH1A1 (0.38) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL5960119 | 0.87 | BHMT (0.37) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL28627379 | 0.83 | EGLN1 (0.35) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL596423 | 0.80 | ALDH1A1 (0.36) | ALDH1A1LMNAMAPTPTGS2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140155646-A1 | PROCESS FOR THE PREPARATION OF A POWDER COMPRISING ONE OR MORE DERIVATIVES OF GLYCINE-N,N DIACETIC ACID AND /OR ONE OR MORE DERIVATIVES OF GLUTAMINE-N,N DIACETIC ACID AND METHYLGLYCINE-N,N DIACETIC ACID TRISODIUM SALT POWDER | BASF SE (DE) | 2014-06-05 | — | — | US | disclosed |
| US-8628684-B2 | Process for the preparation of a powder comprising one or more derivatives of glycine-N,N diacetic acid and/or one or more derivatives of glutamine-N,N diacetic acid and methylglycine-N,N diacetic acid trisodium salt powder | BASF SE (DE) | 2014-01-14 | — | — | US | disclosed |
| US-8609894-B2 | Process for preparing aminopolycarboxylates | BASF SE (DE) | 2013-12-17 | — | — | US | disclosed |
| US-20130165689-A1 | PROCESS FOR PREPARING ONE OR MORE COMPLEXING AGENTS SELECTED FROM METHYLGLYCINEDIACETIC ACID, GLUTAMIC ACID DIACETIC ACID AND SALTS THEREOF | BASF SE (DE) | 2013-06-27 | — | — | US | disclosed |
| US-20120302783-A1 | PROCESS FOR PREPARING AMINOPOLYCARBOXYLATES | BASF SE (DE) | 2012-11-29 | — | — | US | disclosed |
| US-20120046491-A1 | PROCESS FOR THE PREPARATION OF A POWDER COMPRISING ONE OR MORE DERIVATIVES OF GLYCINE-N,N DIACETIC ACID AND /OR ONE OR MORE DERIVATIVES OF GLUTAMINE-N,N DIACETIC ACID AND METHYLGLYCINE-N,N DIACETIC ACID TRISODIUM SALT POWDER | BASF SE (DE) | 2012-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120046491-A1 | PROCESS FOR THE PREPARATION OF A POWDER COMPRISING ONE OR MORE DERIVATIVES OF GLYCINE-N,N DIACETIC ACID AND /OR ONE OR MORE DERIVATIVES OF GLUTAMINE-N,N DIACETIC ACID AND METHYLGLYCINE-N,N DIACETIC ACID TRISODIUM SALT POWDER | GNMT, GLUL, ASNS | ALDH1A1 4842/4885LMNA 1947/4885MAPT 1761/4885 |
| US-20140155646-A1 | PROCESS FOR THE PREPARATION OF A POWDER COMPRISING ONE OR MORE DERIVATIVES OF GLYCINE-N,N DIACETIC ACID AND /OR ONE OR MORE DERIVATIVES OF GLUTAMINE-N,N DIACETIC ACID AND METHYLGLYCINE-N,N DIACETIC ACID TRISODIUM SALT POWDER | GNMT, GLUL, ASNS | ALDH1A1 4853/4885LMNA 1717/4885MAPT 1915/4885 |
| US-20130165689-A1 | PROCESS FOR PREPARING ONE OR MORE COMPLEXING AGENTS SELECTED FROM METHYLGLYCINEDIACETIC ACID, GLUTAMIC ACID DIACETIC ACID AND SALTS THEREOF | GRIK1, DDC, CA1 | ALDH1A1 692/4885LMNA 3668/4885MAPT 2792/4885 |
| US-20120302783-A1 | PROCESS FOR PREPARING AMINOPOLYCARBOXYLATES | ALDH7A1, DDC, PARG | ALDH1A1 120/4885LMNA 2362/4885MAPT 1391/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.